Evidence map›Paper›PMID 34158481›Full record

ArticleNature communications2021

The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis.

Samuel Rivero-Hinojosa, Elena M Pugacheva, Sungyun Kang, Claudia Fabiola Méndez-Catalá, Alexander L Kovalchuk, Alexander V Strunnikov, Dmitri Loukinov, Jeannie T Lee, Victor V Lobanenkov

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Ectopic expression of meiotic cohesin generates chromosome instability in cancer cell line.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Contribution ofFrontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Samuel Rivero-HinojosaLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. sriverohin@childrensnational.org.ORCID 0000-0002-3595-8273
Elena M PugachevaLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. epugacheva@niaid.nih.gov.ORCID 0000-0001-9693-9853
Sungyun KangLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Claudia Fabiola Méndez-CataláLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Alexander L KovalchukLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2761-0442
Alexander V StrunnikovGuangzhou Institutes of Biomedicine and Health, Molecular Epigenetics Laboratory, Guangzhou, China.
Dmitri LoukinovLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Jeannie T LeeDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7786-8850
Victor V LobanenkovLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. vlobanenkov@niaid.nih.gov.ORCID 0000-0001-6665-3635
National Institutes of Health · USAutonomous University of Tlaxcala · MXGuangzhou Institutes of Biomedicine and Health · CNHarvard University · US

Funding

Normal and Pathologic Functions of CTCF and Its Distinct Classes of DNA-targetsZIAAI000860 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LOBANENKOV, VICTOR · 2009 to 2025
$15.4M
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS FactorZIAAI001021 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LOBANENKOV, VICTOR · 2009 to 2025
$12.7M
Regulation of X-Inactivation by Non-Coding RNA LociR01GM058839 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, JEANNIE T · 1999 to 2025
$6.7M
Regulation of X-chromosome Inactivation and Imprinting by Non-coding ElementsR37GM058839 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI LEE, JEANNIE T · 2012 to 2021
$4.1M
NIGMS NIH HHS R01 GM058839NIGMS NIH HHS R37 GM058839
6 · The paper itself

Abstract

CTCF is a key organizer of the 3D genome. Its specialized paralog, BORIS, heterodimerizes with CTCF but is expressed only in male germ cells and in cancer states. Unexpectedly, BORIS-null mice have only minimal germ cell defects. To understand the CTCF-BORIS relationship, mouse models with varied CTCF and BORIS levels were generated. Whereas Ctcf

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCCCTC-Binding FactorDNA-Binding ProteinsHumansInfertility, MaleMaleMeiosisMiceMice, KnockoutPromoter Regions, GeneticProtein BindingRecombination, GeneticRNA-SeqSpermatogenesisSpermatozoaCCCTC-Binding FactorCtcfl protein, mouseCtcf protein, mouseDNA-Binding Proteins

Identifiers

PMID34158481
PMCPMC8219828
OpenAlexW3174333494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.